Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.
“The decision to choose systemic adjuvant therapy warrants careful discussion on its benefits and risks,” researchers wrote.
Investigator studied current treatment patterns and attrition rates in metastatic clear cell renal cell carcinoma using a large, US nationwide cohort.
Researchers conducted a QoL assessment for young children with ALL.
The risk of mortality for patients with colon cancer is significantly higher for those with cannabis-use disorder, compared with use disorders of other substances.
An analysis of 10 cancer treatment sites revealed that many pediatric patients do not receive care pathway-consistent and CPG-consistent care.
Researchers sought to determine whether a pharmacist-led clinic for administering venetoclax would be effective for patients with CLL.
New evidence supports olanzapine-containing regimens as highly effective in preventing chemotherapy-induced nausea and vomiting.
The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.
A team of researchers explain how navigation programs work, who benefits, and how to create a successful navigation program.
The Fatigue Scale provides a reliable measure of fatigue in most populations of pediatric patients with cancer.
